3BY Ltd. specializes in subcontracting turn-key projects of medical components, devices and systems.
3BY...Read more

3BY Ltd. specializes in subcontracting turn-key projects of medical components, devices and systems.
3BY provides production of Medical products in a clean room environment according to highest world class standards, Molding services, sophisticated plastic injection molding services, thermoforming packages (blister), technical design assistance, Automatic assembly and packaging. Our personal and professional attitude has ensured a history of reliable superior output and complete customer satisfaction. 3BY has the ability to be flexible according to the customers needs.

3BY Ltd. provides an outstanding source for sub-contracting and joint product development, offering extensive international experience and industry expertise. 3BY is open to and interested in joint client ventures as well as in the exploration and development of new industry products, and the enhancement and refinement of existing ones by contributing innovative, cost-saving design solutions. As a sophisticated Israeli company, 3BY Ltd. offers powerful reasons to start a professional dialogue on new state of the art manufacturing development opportunities. 

DALI Medical Devices

was founded in 2003 by David Daily and Lior Raday. Since its establishment, DALI has focused on developing novel injectable drug delivery devices and auto-injector...Read more

DALI Medical Devices

was founded in 2003 by David Daily and Lior Raday. Since its establishment, DALI has focused on developing novel injectable drug delivery devices and auto-injector platforms.

Our Vision

To become a leading developer and provider of unique, creative and innovative easy-to-use injection devices.

Our Mission

To develop and bring to market unique, innovative injectable drug delivery devices that help alleviate patients’ fears and limitations, thereby contributing to the success of their medical treatment and improving their overall quality of life.

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low intensity acoustic technology.
The company's patented technology allows for  creation of a miniature transducers that transmit...Read more

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low intensity acoustic technology.
The company's patented technology allows for  creation of a miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible materials surfaces. This unique development may be utilized for a variety of additional medical applications requiring low cost therapeutic ultrasound qualities.
The company's PainShieldTM MD product has gained CE Mark certification and FDA clearance while the UroShieldTM is currently CE mark certified. 
NanoVibronix Inc. is located in Long Island, NY. Its subsidiary, NanoVibronix Ltd. is located in Nesher, Israel.

DirexGroup was established over 20 years ago and has continuously extended its presence in countries and markets worldwide. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various solutions to their clinical...Read more

DirexGroup was established over 20 years ago and has continuously extended its presence in countries and markets worldwide. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various solutions to their clinical needs.
DirexGroup's European headquarters are located in Wiesbaden, Germany with direct responsibility for Europe, Africa and the Middle East. The Group's U.S. operations and FDA approved manufacturing facility is located in Canton, MA.

Today, DirexGroup enjoys a fruitful relationship with Initia Medical Technologies; a collaboration that brings together seasoned market understanding with high-pace development and engineering skills.

DirexGroup introduced in 1986 the Tripter X-1, the groundbreaking concept of a modular compact lithotripter emphasizing a small and mobile device. Direx' Tripter X-1 system eventually became the standard with all competitive devices adopting the ingenuity of the X-1 system architecture and concept.

DirexGroup and Initia introduced in 2003 the Duet shockwave lithotripter, the only such device that applies shockwaves from two sources, allowing for substantial reduction in kidney damage as well as reduced average treatment time.

SyroLight is a leading manufacturer of phototherapeutic medical devices that harness the healing power of Low-Level Narrow Band (“LLNB”) red light.

Ours devices offer non-invasive, drug-free, side-effect-free treatment for hay fever, oral...Read more

SyroLight is a leading manufacturer of phototherapeutic medical devices that harness the healing power of Low-Level Narrow Band (“LLNB”) red light.

Ours devices offer non-invasive, drug-free, side-effect-free treatment for hay fever, oral lesions, chronic pain and rheumatoid arthritis, acne and chronic wounds. These ailments have limited conventional treatments.

SyroLight’s safe, compact, effective, and affordable devices are based on the clinically proven fact that macrophages when exposed to 630 nm low level wavelengths, release factors which stimulate fibroblast proliferation and mediators of wound repair and inflammatory process healing. Aimed directly at the affected area of skin, the light (particularly 630 & 940 nm) penetrates painlessly and safely up to 1.5 cm into the soft cell tissue and so acts on the entire site of inflammation.

In this way, the immune system is activated; the body`s natural healing powers stimulated and the healing process accelerated without side-effects & without the use of drugs or invasive procedures. Syro has a team of scientists which have developed expertise in phototherapy over many years of extensive research and development covered by many well protected patents.

MediTouch established in 2004 with the aim of developing novel occupational and physical therapy rehabilitation equipment based on the proven concepts of active exercise and biofeedback. 
Meditouch has developed optical...Read more

MediTouch established in 2004 with the aim of developing novel occupational and physical therapy rehabilitation equipment based on the proven concepts of active exercise and biofeedback. 
Meditouch has developed optical and image processing technology that determines the position and speed of motion of single or multijoints. Together with occupational, physical therapy and rehabilitation clinical know how Meditouch develops rehabilitation platforms that use active exercises and biofeedback to improve lower and upper extremity function and aid in rehabilitation.
MediTouch firstly targeted hand rehabilitation indications and launched its HandTutor^TM system with CE and FDA certification in 2008. The HandTutor^TM is an innovative hand rehabilitation system that uses active exercise with biofeedback to give occupational and physical therapists a new high tech treatment option to improve hand function. The system in indicated for patients following stroke, Parkinson's disease and other neurology and orthopeadic patients. 
MediTouch is in the prototype development stage of elbow, knee, ankle and hip braces that allow range of motion evaluation and active exercise treatment for patients suffering stroke, or recovering from Total knee, elbow and ankle Orthopedic interventions. 
MediTouch is also combining EMG and TENS electrical stimulation into their rehabilitation platform.

EasyLabour® conveniently and comfortably applies acupressure to specific acupressure points in the lower back area of a woman during birth giving. The method is similar to acupressure as applied by well-trained acupressure...Read more

EasyLabour® conveniently and comfortably applies acupressure to specific acupressure points in the lower back area of a woman during birth giving. The method is similar to acupressure as applied by well-trained acupressure practitioners.

The acupressure points, located over the sacral bone area, are known to be the most efficient acupressure points to ease labour pain. EasyLabour applies gentle, precise pressure simultaneously to these six points just above the buttocks in the lower back, in a way that simulates standard acupressure therapy.  

The comfortable device is attached after labour has begun, when you feel you need pain relief. The intensity and duration is up to you and totally under your control. EasyLabour does not interfere in any way with obstetric procedures or monitors.  

Clinical trials indicated a significant decrease in pain within 5 minutes of application, as well as suggesting shorter pain periods during contractions while using EasyLabour®.

• Natural
• Safe
• Easy to use
• No side-effects
• Small & portable

MacroCure is a biotechnology company focused on the development and commercialization of advanced cell therapy products. The company's first focus of interest is in the arena of wound care.  The technology employs activated white blood cells obtained...Read more

MacroCure is a biotechnology company focused on the development and commercialization of advanced cell therapy products. The company's first focus of interest is in the arena of wound care.  The technology employs activated white blood cells obtained from young (18-40 yrs old) healthy donor blood. The activated cells provide the natural environment for wound healing, and ensure that necessary cell activities and factor secretions are maintained as required for wound healing. This novel concept is the first of its kind in the field of wound therapy.

MacroCure currently manufactures and markets its lead product, CureXcell^TM, in Israel for hard-to-heal wound treatment. The  cell therapy company has its regulatory strategy in place for market approval in North America and Europe.

CureXcell^TM demonstrated favorable results for standard of care (SOC) when treating various chronic wounds. Clinical trials in Israel have shown a 90% reduction of the mortality rate in patients with deep sternal wound infections and a markedly improved healing rate for severe pressure ulcers. Since the introduction of CureXcell^TM to the market, more than 4,000 patients have been treated in Israel with this advanced cell therapy. No serious adverse events have been reported 

Meditex Ltd. was established in 1974, by Mr. Uriel Rosen O.M. and became in a short time one of the leading manufacturers of orthopedic bandages and health supports in Israel as well as worldwide under the brand name \"URIEL\".

The...Read more

Meditex Ltd. was established in 1974, by Mr. Uriel Rosen O.M. and became in a short time one of the leading manufacturers of orthopedic bandages and health supports in Israel as well as worldwide under the brand name "URIEL".

OrSense is a medical device company that develops and commercializes patient monitoring solutions for non-invasive continuous measurements of hemoglobin, oxygen saturation, glucose and other blood parameters. OrSense's NBM-200MP monitors and displays oxygen...Read more

OrSense is a medical device company that develops and commercializes patient monitoring solutions for non-invasive continuous measurements of hemoglobin, oxygen saturation, glucose and other blood parameters. OrSense's NBM-200MP monitors and displays oxygen saturation of Hb (SpO2), low signal oximetry, SpO2, pulse rate, plethysmogram and hemoglobin, all non-invasively and continuously. The system is designed for use in hospitals including operating and recovery rooms and intensive care units as well as in outpatient sites and emergency services.

OrSense’s non-invasive hemoglobin/hematocrit monitor was granted the CE approval and was tested on over 4,000 patients and donors at 15 sites in the U.S. and Europe. The Company's products are based on its proprietary Occlusion Spectroscopy technology, which overcomes key obstacles that hinder the performance of competing approaches.

OrSense next generation products target non-invasive monitoring of blood glucose in the hospital and for home use. The CE approved glucose monitor was tested on over 450 diabetic subjects. Results indicate performance similar to those of invasive glucose sensors on the market today.

OrSense’s products address markets that represent annual revenue opportunities of over $10 billion.

OrSense has a multidisciplinary staff  with over half of the R&D personnel holding  PhD/MDs including scientists, mathematicians, engineers and an experienced management team. The company is supported by internationally recognized scientists from leading research centers.

OrSense’s intellectual property portfolio consists of 51 granted patents with over 20 additional applications in process.

Investors in OrSense are led by Israel Health Care Ventures and STAR Ventures, two of Israel’s leading venture capital firms. Other investors include, Carlo Salvi, Tamar ventures, Unicycle, Medison, Lewis Trust Group (LTG) and Shimon Eckhouse.

Mego Afek specializes in manufacture of non-invasive medical devices, pressure control systems and high-frequency welded products including inflatable structures and components.

Mego Afek is divided into two...Read more

Mego Afek specializes in manufacture of non-invasive medical devices, pressure control systems and high-frequency welded products including inflatable structures and components.

Nexense is a leading Israeli R&D company founded in 2001 partly held by GE Healthcare. Nexense developed a unique sensors platform capable of measuring most physical parameters close to molecular precision with signal to noise ratio that exceeds the state of the art....Read more

Nexense is a leading Israeli R&D company founded in 2001 partly held by GE Healthcare. Nexense developed a unique sensors platform capable of measuring most physical parameters close to molecular precision with signal to noise ratio that exceeds the state of the art. Fortune 500 companies including: Samsung, Ford, General Motors, Johnson & Johnson and others used Nexense sensing platform to develop new products or to enhance existing products and applications. Nexense sensors platform and its IP are protected by over 60 patents and applications world wide. Nexense develops innovative products and collaborates with world leading companies in various industries including medical, automotive, homeland security and wireless communications. We invite investors and leading companies to learn more about our sensing platform and to explore business and technological opportunities.

Airway management ranks among the highest priorities in clinical care.  Timely, effective and decisive airway management makes the difference between life and death. ETView was founded in 2004, with the mission of improving patient health and lowering...Read more

Airway management ranks among the highest priorities in clinical care.  Timely, effective and decisive airway management makes the difference between life and death. ETView was founded in 2004, with the mission of improving patient health and lowering the high costs of medical care. Featured on the show ER as an innovative medical device, the TVT is an endotracheal tube embedded with a miniature camera and light source that provides an effective and safe solution for enhanced airway management and difficult intubations. The TVT is improving the quality of medical care wherever intubation is performed. ICU, OR, ER and pre-hospital EMS.
In addition to the clinical applications of the TVT, ETView's Intubation Trainer is a modified version of the TVT used for teaching and refreshing the intubation skills of medical students, EMS personnel and hospital staff. ETView has distribution in Spain, Austria, Italy, Turkey, Greece, and Israel. The TVT is in clinical use in over 40 hospitals. ETView operates within the framework of the Misgav Venture Accelerator. 

EarlySense is bringing to market an innovative contact-free patient supervision technology.
EarlySense’s continuous early sensing capabilities and patient management tools empower the medical staff in the unmonitored units to improve clinical...Read more

EarlySense is bringing to market an innovative contact-free patient supervision technology.
EarlySense’s continuous early sensing capabilities and patient management tools empower the medical staff in the unmonitored units to improve clinical outcomes and reduce pressure ulcers and patient falls by measuring key parameters through a sensor places underneath the patient’s mattress.
The continuous patient supervision device that follows and documents patients' vital signs and movement, allows nursing staff to proactively reduce adverse events such as pressure ulcers and falls and prevent critical transfers to higher levels of car
EarlySense was founded in 2004 and is headquartered in Israel with offices in Boston, massachusett
EarlySense's  system bridges the critical time gap between patient deterioration and clinician intervention. EarlySense's technology offers a timely solution for detecting changes in a patient’s condition, while also assisting nurses to focus on the patients who need their immediate attention.

Click Here to Read Testimonials